Would you recommend PMRT in a patient with dermal invasion as the sole adverse feature after a skin sparing mastectomy for an early stage breast cancer?
In the absence of epidermal invasion and absence of dermal lymphatic invasion (DLI)
Answer from: Radiation Oncologist at Community Practice
Pathological dermis involvement in these early stage patients is function of location ( like retroareolar or superficial location) rather than aggressiveness of disease and thus outcome is more like early stage disease
In absence of other adverse factor I would favor observation